WHO ICTRP trial
Effect of elobixibat on bile acid metabolism in patients with primary biliary…
JPRN-UMIN000039146 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000039146 |
|---|---|
| Public title | Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver |
| Scientific title | Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver - Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver |
| Primary sponsor | Tokai University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | primary biliary cholangitis or fatty liver |
| Registration date | Jan 16, 2020 |
| Target size | 40 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: